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A B S T R A C T
Objectives: Cases of undiagnosed severe febrile rhabdomyolysis in refugees coming from West Africa,
mainly from Nigeria, has been observed since May 2014. The aim of this study was to describe this
phenomenon.
Methods: This was a multicentre retrospective observational study of cases of febrile rhabdomyolysis
reported from May 2014 to December 2016 in 12 Italian centres.
Results: A total of 48 cases were observed, mainly in young males. The mean time interval between the
day of departure from Libya and symptom onset was 26.2 days. An average 8.3 further days elapsed
before medical care was sought. All patients were hospitalized with fever and very intense muscle aches.
Creatine phosphokinase, aspartate aminotransferase, and lactate dehydrogenase values were abnormal
in all cases. The rhabdomyolysis was ascribed to an infective agent in 16 (33.3%) cases. In the remaining
cases, the aetiology was undeﬁned. Four out of seven patients tested had sickle cell trait. No alcohol abuse
or drug intake was reported, apart from a single reported case of khat ingestion.
Conclusions: The long incubation period does not support a mechanical cause of rhabdomyolysis.
Furthermore, viral infections such as those caused by coxsackievirus are rarely associated with such a
severe clinical presentation. It is hypothesized that other predisposing conditions like genetic factors,
unknown infections, or unreported non-conventional remedies may be involved. Targeted surveillance of
rhabdomyolysis cases is warranted.
© 2017 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Rhabdomyolysis is a complex medical condition involving the
rapid breakdown of damaged skeletal muscle. The severity of the
illness ranges from asymptomatic elevations of serum creatine
phosphokinase (CPK) to life-threatening diseases such as cardiac
arrhythmia, acute renal failure, and even death. The characteristic
triad of complaints, i.e. muscle pain, weakness, and pigmenturia, is
seen in less than 10% of patients (Zutt et al., 2014).
According to the International Organization for Migration,
153 842 people arrived directly in Italy via the sea in 2015 and
181436 people in 2016, mainly coming from Nigeria, Eritrea,
Guinea, Ivory Coast, Gambia, Senegal, Mali, and Sudan (Interna-
tional Organization for Migration, 2017). An increasing number of
cases of febrile rhabdomyolysis have been observed in these
migrants since May 2014, and so far there has been no speciﬁc
aetiological diagnosis. The aim of this study was to report and
describe this phenomenon.
Materials and methods
This was a multicentre retrospective observational study of
cases of febrile rhabdomyolysis reported from May 2014 to
December 2016 in 12 Italian centres: nine infectious diseases
and tropical medicine units, two internal medicine units, and one
refugee centre (Figure 1).
Febrile rhabdomyolysis was deﬁned as an increase in CPK levels
(1000 IU/l) associated with myalgia and fever (>38 C). Patient
demographic, clinical, and travel-related data were collected using
a standardized anonymous questionnaire and were entered into a
database. Data were collected retrospectively and analysed using
Microsoft Ofﬁce Excel 2010 (Microsoft Inc., Redmond, WA, USA).
Categorical variables were expressed as the number and propor-
tion, and continuous variables were expressed as the mean 
standard deviation (SD). The study was conducted under the
provisions of the Declaration of Helsinki and in accordance with
the International Conference on Harmonization Consolidated
Guideline on Good Clinical Practice. Since this study was
retrospective and non-pharmacological, written informed consent
was not provided. In Italy, ethical authorization for these studies is
not required (see Italian guidelines for the classiﬁcation and
conduct of observational studies, established by the Italian Drug
Agency, “Agenzia Italiana del Farmaco-AIFA” on March 20, 2008).
Results
A total of 48 cases were identiﬁed; 43 were male (89.6%), and
their mean age was 22.4  5.8 years. They all came from West
Africa, mainly from Nigeria (58.3%) (Figure 2). Libya was the
departure port in all cases. After their arrival in Italy, all patients
were hosted in speciﬁc shelter centres, according to ItalianFigure 1. Number of cases reporimmigration policies. The mean time interval between the day
of departure from Libya and symptom onset was 26.2  39.5 days
(range 2–252 days), and an average further 8.3  7.85 days elapsed
before medical care was sought. The mean duration of sea travel
was 1.7  1.26 days.
Twenty-two patients (45.8%) had travelled between September
and April and 20 had travelled between May and August (this
information was not available for six patients). All patients had a
fever and very intense muscle aches, and were unable to stand or
walk. CPK, aspartate aminotransferase, and lactate dehydrogenase
values were abnormal in all cases (Table 1). Seventeen patients
(35.4%) reported having a forced position during travel. No
seawater ingestion was reported and no case of hypernatraemia
was identiﬁed: the mean serum sodium value was 137  1.26
mmol/l.
The rhabdomyolysis was ascribed by the treating physicians to
an infective agent in 16 (33.3%) cases. In detail, Epstein–Barr virus
(EBV) DNA was detected in eight of 32 patients tested, IgM for
coxsackievirus was detected in ﬁve of 27 cases tested, and IgM for
cytomegalovirus was identiﬁed in three of 29 cases tested (Table 2).
The aetiology was undeﬁned in the remaining cases. The most
frequent infectious causes of rhabdomyolysis were excluded. Four
out of seven patients who were tested for abnormal haemoglobin
had sickle cell trait (SCT) and one patient had haemophilia A.
All patients were asked about drug and alcohol abuse, but none
reported either, with the exception of one patient who declared
Catha edulis (khat) consumption during his stay in Libya, 2–3
weeks before symptom onset.
Only one patient was treated with rifampicin, isoniazid, and
pyridoxine before symptom occurrence. Following supportive
treatment with hydration, almost all patients recovered complete-
ly in about a week. However, they were often symptomatic for
months. Two were hospitalized in the intensive care unit and one
patient had acute kidney injury.
Discussion
This study describes 48 cases of rhabdomyolysis in refugees
coming from West Africa. The phenomenon caught the authors’
attention because of the severity of the symptoms, the inability to
obtain a deﬁnitive diagnosis, and the consistent number of cases.
Cases were observed in centres distributed throughout Italy, from
the north to the south. Up to 20% of individuals in the general
population have an asymptomatic increase in serum CPK, and this
particularly affects the black race (Gabow et al., 1982). Neverthe-
less, the presence of severe symptoms and fever, as well as the
young age of the present study cases, prompted further inves-
tigations to determine an aetiological cause.
Many causes of rhabdomyolysis have been identiﬁed and
reported in the literature, and these can be categorized into
acquired and inherited causes (Gabow et al., 1982; Huerta-Alardinted from each Italian Centre.
Figure 2. Country of residence of refugees.
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possible infectious aetiology, EBV has been associated with the
development of rhabdomyolysis, but only rarely (Roychowdhury,
2007), and a wide spectrum of muscle disorders caused by
coxsackievirus B, ranging from acute non-speciﬁc myalgia to
rhabdomyolysis, has been described (Fodili and van Bommel,
2003; Gómez et al., 2008; Marinella, 1998; Wang et al., 2006).
A mechanical cause of rhabdomyolysis should also be consid-
ered. However, the long incubation period is not consistent with
this hypothesis. It is known that CPK increases approximately 2–
12 h after the onset of muscle injury, reaching a peak concentration
after 24–72 h (Zutt et al., 2014). In the cases in this study, the mean
time interval between travel and symptom occurrence was
26.2  39.5 days. In more detail, the symptoms occurred about 2
months after arrival in three cases, and in one case 252 days
elapsed between arrival and the clinic visit date.
It could be hypothesized that a common viral infection, like
coxsackievirus B, could have triggered the rhabdomyolysis because
of underlying muscle damage due to the patient’s forced position
during travel. Otherwise viral infections caused by EBV and
coxsackievirus are only rarely associated with such a severe clinical
presentation. Furthermore, in the authors’ experience, serological
tests were positive only in a minority of cases (25% and 18.5% of
cases, respectively). The ingestion of sea water has recently been
reported as a cause of hypernatremia and rhabdomyolysis in
African migrants arriving in Lampedusa through the Strait of SicilyTable 1
Laboratory tests at presentation (mean  standard deviation
values).
WBC (109/l) (n = 48/48) 5.87  3.1
RBC (109/l) (n = 48/48) 4.78  5.59
Hb (g/dl) (n = 48/48) 13.2  1.61
PLT (109/l) (n = 46/48) 156  46.4
AST (U/l) (n = 47/48) 355.8  240.1
ALT (U/l) (n = 48/48) 142.2  158.2
GGT (U/l) (n = 37/48) 50.9  47.6
CPK (U/l) (n = 48/48) 8422.2  6630.8
Creatinine (mg/dl) (n = 35/48) 0.98  0.41
LDH (U/l) (n = 32/48) 722.8  399.04
Myoglobin (ng/ml) (n = 14/48) 2088.9  1299.0
CRP (mg/l) (n = 14/48) 33.9  38.2
ALT, alanine aminotransferase; AST, aspartate aminotransferase;
CPK, creatine phosphokinase; CRP, C-reactive protein; GGT, gamma-
glutamyl transferase; Hb, haemoglobin; LDH, lactate dehydroge-
nase; PLT, platelet count; RBC, red blood cell count; WBC, white
blood cell count.(Pasta and Mesa Suero, 2012). Nevertheless, no cases of sea water
ingestion were reported in the study population and their
electrolyte balance was always normal.
All patients were asked about drug or alcohol abuse, but none
reported this except for one patient who declared Catha edulis
(khat) consumption during his stay in Libya, 2–3 weeks before
symptom onset. Khat is a ﬂowering plant native to the Horn of
Africa and the Arabian Peninsula, classiﬁed by the World Health
Organization as a drug of abuse. It is used as a stimulant for its
amphetamine-like effect, causing excitement, loss of appetite, and
euphoria. This risk factor must be further addressed in a
prospective manner in the future, as patients may be reluctant
to disclose the intake or abuse of illicit herbs or drugs.
Different genetic defects causing various neuromuscular and
metabolic disorders are known to be associated with rhabdomy-
olysis. In some instances, rhabdomyolysis may be due to a
combination of environmental triggering causes combined with
predisposing genetic factors that may well be overlooked.
Therefore, the risk of recurrence is high if the genetic diagnosis
is not considered (Scalco et al., 2015).
The common geographic area of origin suggests a genetic
predisposition to rhabdomyolysis. Many genetic variants have
been described associated with rhabdomyolysis secondary to
trauma, strenuous exercise, speciﬁc drugs, and myopathies. Of
note, several case reports published since the early 1970s have
described signiﬁcant morbidity and mortality of acute exertional
rhabdomyolysis in patients with SCT. A case of severe exertional
rhabdomyolysis after a 1.5 mile run was reported in a 27-year-old
medical doctor who had a past medical history signiﬁcant only for
SCT (Makaryus et al., 2007). In the present study sample, four out of
seven patients screened for SCT were positive. Despite the small
sample, it may be worth looking for this and possibly other genetic
predisposing factors that may be common to refugees coming from
West Africa.
Other haematological disorders and haemoglobinopathies have
been recognized as associated with rhabdomyolysis, such as
glucose-6-phosphate dehydrogenase (G6PDH) deﬁciency (Mangat
et al., 2014) and thalassemia (Niwa et al., 1979), especially in
situations of stress, after exposure to a strong oxidant, food items,
or medicines, or drug intake.
Another recent report observed a signiﬁcant difference in
coenzyme Q10 (CoQ10) between healthy African Americans and
whites, indicating that higher creatine phosphokinase (CPK) and
lower CoQ10 are associated with severe exertional rhabdomyolysis
only in African Americans. The CK to CoQ10 ratio is even more
Table 2
Diagnostic tests.
Pathogen Laboratory evidence of recent or chronic active infectiona,n/N (%) Laboratory evidence of non-immunity, n/N (%) where appropriate
Adenovirus 0/15 (0) 10/15 (66.6)
CMV 3a/29 (10.3) 3/29 (10.3)
Coxsackievirus 5a/27 (18.5) 0/27 (0)
EBV 8b/32 (25) 21/32 (65.6)
Plasmodium falciparum 1c/44 (2.27) –
Dengue 0/17 (0) 13/17 (76.4)
Schistosoma 3d/10 (30) –
Chikungunya 2e/10 (20) –
HCV 0/35 (0) –
HBV 3/38 (7.9) –
HIV 2/39 (5.1) –
n, number of patients tested; N, number of patients with available data; CMV, cytomegalovirus; EBV, Epstein–Barr virus; HBV, hepatitis B virus; HCV, hepatitis C virus.
a IgG and IgM positive or documented seroconversion (from negative to positive IgG).
b Eight patients with positive EBV DNA.
c Thin and thick blood smear positive.
d Three patients with Schistosoma IgG positive (probable chronic infection).
e Two patients positive for both chikungunya IgG and IgM.
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risk factors and multiple required deﬁciencies in the same
individual must be considered (Prince et al., 2015).
An outbreak of Haff disease has been described recently in
Salvador, Brazil, starting early December 2016, and several cases
have occurred in recent years in Eastern Europe, Sweden, China,
Japan, and the USA (Bandeira et al., 2017; Diaz, 2015). Haff disease
is a syndrome of myalgia and rhabdomyolysis that occurs within
24 h after consuming cooked seafood; it is caused by an as yet
unidentiﬁed heat-stable toxin. No data about the ingestion of ﬁsh
were collected from the present study patients, but Haff disease
was excluded from the physicians’ working diagnosis due to the
presence of fever (which has not been described in Haff disease),
the heterogeneous incubation period, and the distribution
throughout the country. Furthermore, no cases have been reported
in the literature in Italian people, and this allowed the possibility of
a disease related to the consumption of Italian ﬁsh being ruled out.
This study has several limitations. Data were not collected
systematically in all infectious diseases units of the country, so
they may not be representative of all migrants with rhabdomyoly-
sis. This was not a population-based study, so rates and risks could
not be determined. The data collection system changed with time.
The progressive increase in the number of cases observed may have
been due in part to a raised awareness. Moreover, the medical
records were not always homogeneous. Despite these limitations,
this study provides the best current estimates available on
rhabdomyolysis in refugees.
In conclusion, rhabdomyolysis is a potentially serious clinical
illness. The consistent number of cases observed served as a wake-
up call and prompted the authors to wonder whether something
unusual and unexpected was occurring. Genetic predisposing
factors must be considered and studied, and a full analysis for
haemoglobinopathies and G6PDH deﬁciency should be performed.
A detailed history of drug/herbal intake is also essential.
Additionally, a more uniform and organized data collection system
for these patients is necessary in order to better understand the
phenomenon. Targeted surveillance of rhabdomyolysis cases is
warranted.
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